Assessment of Tumor Volume Dynamics and Outcome After Radiosurgery for the Treatment of Vestibular Schwannoma: A Single-Center Experience.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2021 Vol.42(6) p. e750-e757

Ermiş E, Egger R, Leiser D, Anschuetz L, Raabe A, Abu-Isa J, Manser P, Aebersold DM, Wagner F, Herrmann E

관련 도메인

Abstract

[OBJECTIVE] To assess the factors affecting early local and audiometric outcomes in vestibular schwannoma (VS) patients treated with stereotactic radiosurgery (SRS).

[STUDY DESIGN] A retrospective review of medical records.

[SETTING] Tertiary referral center.

[PATIENTS] Records of all adult patients who underwent SRS between 2010 and 2016 for the treatment of VS were retrospectively reviewed. Patients treated with microsurgery or multi-fractionation schemes, and those who had neurofibromatosis type 2, were excluded.

[INTERVENTION] SRS, tumor volume/size measurements.

[MAIN OUTCOME MEASURES] The impact of tumor volume dynamics on the early local and hearing-related outcomes, together with the factors that influence them following SRS, and comparison of different tumor size measurement methods.

[RESULTS] From 2010 to 2016, 53 patients underwent single fraction SRS of 12 Gy. Median follow-up time was 32 months (range, 6-79). At the last follow-up, only one patient had clinical progression. Age less than or equal to 65 years (p = 0.04; odds ratio [OR]: 0.17; 95% confidence interval [CI]: 0.03-0.93) and baseline pure-tone average (PTA) level less than or equal to 30 dB (p = 0.03; OR: 0.90; 95% CI: 0.84-0.96) were associated with maintenance of serviceable hearing. On multivariate analysis, PTA remained significant (p = 0.01; OR: 0.04; 95% CI: 0.003-0.45). In patients with a loss of serviceable hearing, the mean volume increase tended to be higher than in the patients whose hearing was maintained. The linear measurement method underestimated, and the A × B × C/2 equation overestimated, the radiological progression compared with 3D-volumetric delineations.

[CONCLUSION] During the median observation period of almost 3 years, we reported our early outcome results. Tumor volume increase may have an impact on serviceable hearing loss after SRS. Currently there is no widely accepted method for the evaluation of post-SRS response. Linear measurement and the A × B × C/2 equation produce less reliable estimates of radiological progression compared with 3D-volumetric delineations. Accurate volume measurements with 3D delineations should be considered as part of clinical routine for assessing progression and deciding on salvage therapies.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 microsurgery 미세수술 dict 1
약물 [OBJECTIVE] scispacy 1
약물 [MAIN OUTCOME scispacy 1
약물 [OR] scispacy 1
질환 SRS → stereotactic radiosurgery C3846112
Radiosurgery, Stereotactic
scispacy 1
질환 neurofibromatosis type 2 C0027832
Neurofibromatosis 2
scispacy 1
질환 serviceable hearing scispacy 1
질환 a loss of scispacy 1
질환 serviceable hearing loss scispacy 1
질환 post-SRS scispacy 1
질환 Radiosurgery scispacy 1
질환 Tumor C0027651
Neoplasms
scispacy 1
질환 Vestibular Schwannoma C0027859
Acoustic Neuroma
scispacy 1
기타 patients scispacy 1
기타 patient scispacy 1

MeSH Terms

Adult; Follow-Up Studies; Humans; Neuroma, Acoustic; Radiosurgery; Retrospective Studies; Treatment Outcome; Tumor Burden

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문